MedTrace Logo

Scratch and Sleep Quantification in Atopic Dermatitis

NCT03490877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2020-02-12

No results posted yet for this study

Summary

Atopic dermatitis (AD) is a chronic type of eczema affecting approximately 10% of adults and 12% of children in the US. The intense itching (pruritus) associated with AD can be significantly disruptive to sleep and quality of life for both the patients and their caregivers. AD is challenging to describe and measure. The purpose of this study is to see if we can reliably measure how much people with AD scratch and how scratching interferes with sleep and quality of life by using digital sensors, sleep studies and patient-reported information.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Lisa A. Beck, MD · University of Rochester

  • Earl R. Dorsey, MD MBA · University of Rochester Medical Center/Center for Health+Technology

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2019-04-30
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03490877 on ClinicalTrials.gov